This topic contains a solution. Click here to go to the answer

Author Question: What effect will occur if a patient being treated with naltrexone (ReVia) for substance abuse ... (Read 123 times)

MGLQZ

  • Hero Member
  • *****
  • Posts: 579
What effect will occur if a patient being treated with naltrexone (ReVia) for substance abuse ingests opioids or alcohol?
 
  a. Increased euphoria
  b. Nausea, vomiting, and diarrhea
  c. Deep sedation
  d. An absence of the high associated with drugs

Question 2

What must be administered before glucose infusions for a patient in alcohol withdrawal to prevent Wernicke's encephalopathy?
 
  a. Chlordiazepoxide (Librium)
  b. Thiamine
  c. Diazepam (Valium)
  d. Bromocriptine (Parlodel)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

chloejackso

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

ANS: D
Naltrexone is an opioid antagonist prescribed to block the pharmacologic effects of the high associated with opioids and alcohol. Studies report less alcohol craving and fewer drinking days, especially when naltrexone is combined with psychosocial treatment. Naltrexone prevents the euphoria associated with taking drugs like opioids and alcohol. These are symptoms of taking alcohol in combination with disulfiram (Antabuse). Naltrexone is not sedating.

Answer to Question 2

ANS: B
Thiamine and multiple vitamins should be administered routinely to patients in alcohol withdrawal. Intravenous fluid therapy for rehydration may be necessary, but thiamine must be administered before glucose infusion to prevent Wernicke's encephalopathy. Benzodiazepines are given for treatment of anxiety and seizures associated with alcohol withdrawal. Bromocriptine is not used to prevent Wernicke's encephalopathy.





 

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

The most common childhood diseases include croup, chickenpox, ear infections, flu, pneumonia, ringworm, respiratory syncytial virus, scabies, head lice, and asthma.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

For a complete list of videos, visit our video library